Evaluation of the Structural Modification Effect of Diacerein (Artrodar®) in Knee Osteoarthritic Patients
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This study evaluates the structure-modifying effect of Diacerein (Artrodar ®) in knee
osteoarthritic (OA) patients by measuring total cartilage volume from magnetic resonance
imaging (MRI) of the knee. Half of participants will receive Diacerein (Artrodar ®), while
the other half will receive a placebo.